Corona Vaccine

The National COVID-19 symposium scientific committee invites submission of the original work on COVID-19 case management. The National Conference aims to bring together the lesson learnt during the management of…

HIGHLIGHTS The COVAX Facility has notified participating economies that deliveries of doses from the Serum Institute of India (SII) will be delayed in March and April. Delays in securing supplies…

Assessments by World Bank and partners provide insights into more than 120 countries’ readiness to safely distribute vaccines WASHINGTON, March 18, 2021 – As countries undertake the largest vaccination campaign in…

As of 17 March 2021, more than 120 million cases of COVID-19 infections, with more than 2 million deaths, had been reported globally.  Vaccination remains a critical tool to help…

12 March 2021 News release Geneva The World Health Organization (WHO) listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all countries and for COVAX roll-out. The…

The World Health Organization (WHO) and Chubb Limited (NYSE: CB), through ESIS Inc., a Chubb company, signed an agreement on behalf of the COVAX Facility on 17 February 2021 for…

Declaration We must accelerate vaccine equity for all health workers – now Health and care workers have been at the forefront of the pandemic response: often under protected and over…

AstraZeneca/Oxford-developed vaccines to reach countries in the coming weeks 15 February 2021 The World Health Organization (WHO) listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the…

The Department of Drug Administration (DDA) has decided to approve ‘COVISHIELD’ COVID-19 vaccine for emergency use in Nepal. DDA provided the conditional permission for emergency authorisation of COVISHEILD vaccine against…

New Delhi, 13 January 2021 – On this day in 2011, WHO South-East Asia Region reported its last case of wild poliovirus from West Bengal in India. A decade later,…